Alxn

Website Links

Description

Welcome to Alexion Pharmaceuticals. Before touring our website, we would like to give you a quick overview of Alexion. Alexion Pharmaceuticals is a leading American biotechnology company. We were formed in 1992, listed on NASDAQ in 1996, and as of mid-2007 employ approximately 400 people at our Cheshire headquarters, Smithfield Rhode Island manufacturing plant, and Paris, France European headquarters. The U.S. Food and Drug Administration approved our first product, Soliris (eculizumab), for sale in March, 2007. Soliris is indicated for the reduction of hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare, disabling, and life-threatening blood disorder defined by chronic red blood cell destruction. Soliris is the first therapy ever approved for PNH. Since our founding by scientists from Yale University, other research universities and the pharmaceutical industry, we have held a determined focus on translating cutting edge science into novel therapeutic products. Alexion's strategy is to build on our strong scientific and product development base to develop novel antibody therapeutics targeting the treatment of patients with a wide array of severe disease states, including hematologic diseases, cancer, and autoimmune disorders. Alexion is dedicated to working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions...

Products & services

Similar companies nearby